© Reuters Gilead Earnings, Revenue Beat in Q1
Investing.com – Gilead (NASDAQ:) reported on Thursday first quarter that beat analysts’ forecasts and revenue that topped expectations.
Gilead announced earnings per share of $2.12 on revenue of $6.59B. Analysts polled by Investing.com anticipated EPS of $1.8 on revenue of $6.28B.
Gilead shares are down 9% from the beginning of the year, still down 16.95% from its 52 week high of $74.12 set on December 30, 2021. They are outperforming the Nasdaq which is down 17.73% from the start of the year.
Gilead shares lost 0.91% in after-hours trade following the report.
Gilead follows other major Healthcare sector earnings this month
Gilead’s report follows an earnings beat by UnitedHealth on April 14, who reported EPS of $5.49 on revenue of $80.15B, compared to forecasts EPS of $5.36 on revenue of $78.73B.
J&J had beat expectations on April 19 with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.62B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Be the first to comment